Skip to main content
Published locations for PFS better with first-line pazopanib vs. sorafenib in mRCC
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
PFS better with first-line pazopanib vs. sorafenib in mRCC
User login
Username
Password
Reset your password
/content/pfs-better-first-line-pazopanib-vs-sorafenib-mrcc
/oncologypractice/article/149516/renal-cell-carcinoma/pfs-better-first-line-pazopanib-vs-sorafenib
/hematology-oncology/article/149516/renal-cell-carcinoma/pfs-better-first-line-pazopanib-vs-sorafenib